| scholarly article | Q13442814 |
| P50 | author | Andrea Schneider | Q56955657 |
| P2093 | author name string | Randi J Hagerman | |
| Reymundo Lozano | |||
| Flora Tassone | |||
| Sultana M H Faradz | |||
| Patrick E Adams | |||
| Zukhrofi Muzar | |||
| P2860 | cites work | The fragile-X premutation: a maturing perspective | Q24533443 |
| Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment | Q24681779 | ||
| Methadone-Induced Toxic Leukoencephalopathy: Diagnosis and Follow-up by Magnetic Resonance Imaging Including Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Maps | Q28296702 | ||
| Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain | Q28363748 | ||
| White matter hyperintensity burden and disability in older adults: is chronic pain a contributor? | Q33621798 | ||
| The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis | Q33641052 | ||
| A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome | Q33652584 | ||
| Advances in understanding the molecular basis of FXTAS | Q33871325 | ||
| White matter abnormalities correlating with memory and depression in heroin users under methadone maintenance treatment | Q34229954 | ||
| White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study | Q34242233 | ||
| Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. | Q34364858 | ||
| Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study | Q34568598 | ||
| Microstructural white matter changes in the corpus callosum of young people with Bipolar Disorder: a diffusion tensor imaging study | Q34634663 | ||
| Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative | Q34861498 | ||
| Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study | Q74252407 | ||
| CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTAS | Q34955465 | ||
| Decline in intelligence is associated with progression in white matter hyperintensity volume | Q35489796 | ||
| Fibromyalgia in fragile X mental retardation 1 gene premutation carriers | Q35569505 | ||
| A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. | Q36329311 | ||
| Longitudinal changes in white matter integrity among adolescent substance users | Q36542430 | ||
| White matter in learning, cognition and psychiatric disorders | Q36793946 | ||
| Fragile X-associated tremor/ataxia syndrome: an aging face of the fragile X gene. | Q37057006 | ||
| Altered white matter microstructure in adolescent substance users | Q37325687 | ||
| Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration | Q37471792 | ||
| Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome | Q37580522 | ||
| Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study | Q39795105 | ||
| Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. | Q40221428 | ||
| Methadone-induced toxic brain damage | Q41878741 | ||
| Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings. | Q43247687 | ||
| Cognitive impairment in methadone maintenance patients | Q44026538 | ||
| White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects | Q45020128 | ||
| Neuroimaging evidence for the deficit subtype of schizophrenia | Q45035322 | ||
| White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study | Q46214513 | ||
| Plasma vitamin B12 status and cerebral white-matter lesions | Q46269265 | ||
| Decreased frontal white-matter volume in chronic substance abuse | Q46590337 | ||
| Increased white matter hyperintensities in male methamphetamine abusers | Q46590888 | ||
| Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study | Q46827956 | ||
| Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors | Q48278329 | ||
| Progression of tremor and ataxia in male carriers of the FMR1 premutation | Q48354732 | ||
| Increased risk of death in community-dwelling older people with white matter hyperintensities on MRI. | Q48454586 | ||
| White matter hyperintensities are an independent predictor of physical decline in community-dwelling older people | Q48499876 | ||
| Deaths in the first two weeks of maintenance treatment in NSW in 1994: identifying cases of iatrogenic methadone toxicity | Q48531250 | ||
| Disrupted integrity of white matter in heroin-addicted subjects at different abstinent time | Q48548909 | ||
| Depression in methadone maintenance treatment patients: rate and risk factors | Q48651077 | ||
| Neuropsychological performance of methadone-maintained opiate users. | Q48720421 | ||
| Clinical and radiological findings in methadone-induced delayed leukoencephalopathy | Q48726501 | ||
| Age related white matter changes predict stroke death in long term follow-up | Q48729967 | ||
| Cerebral small-vessel disease and decline in information processing speed, executive function and memory | Q48860735 | ||
| White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort | Q49047020 | ||
| White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study. | Q51901873 | ||
| Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. | Q51973841 | ||
| Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. | Q52171111 | ||
| White matter microstructure in opiate addiction. | Q52297604 | ||
| White matter hyperintensities in subjects with bipolar disorder. | Q53607580 | ||
| Expanded clinical phenotype of women with the FMR1 premutation. | Q55420262 | ||
| Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). | Q55497214 | ||
| Immune-mediated disorders among women carriers of fragile X premutation alleles. | Q55637365 | ||
| Brain tissue volumes and small vessel disease in relation to the risk of mortality | Q57621282 | ||
| Silent Brain Infarction and Subcortical White Matter Lesions Increase the Risk of Stroke and Mortality: A Prospective Cohort Study | Q58455771 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1354-1359 | |
| P577 | publication date | 2015-04-21 | |
| P1433 | published in | American Journal of Medical Genetics | Q4744254 |
| P1476 | title | Methadone use in a male with the FMRI premutation and FXTAS. | |
| P478 | volume | 167 |
| Q44451958 | A Majority of FXTAS Cases Present with Intranuclear Inclusions Within Purkinje Cells |
| Q26781265 | Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder |
| Q96135141 | Fragile X associated neuropsychiatric disorders in a male without FXTAS |
| Q59335598 | Fragile X-Associated Neuropsychiatric Disorders (FXAND) |
| Q36239663 | Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s |
| Q38875623 | Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management |
| Q63470480 | General Anesthetic Use in Fragile X Spectrum Disorders |
| Q58597509 | Increased Severity of Fragile X Spectrum Disorders in the Agricultural Community of Ricaurte, Colombia |
| Q28390629 | Phenobarbital use and neurological problems in FMR1 premutation carriers |
| Q58719610 | Presence of Middle Cerebellar Peduncle Sign in Premutation Carriers Without Tremor and Ataxia |
| Q53799975 | Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length. |
| Q91918711 | [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment] |
Search more.